JCRB0181 KP-2
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0181 | Cell Name | KP-2 |
---|---|---|---|
Profile | Human pancreatic tumor cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 65 |
Identity | available | Tissue for Primary Cancer | pancreas |
Case history | moderately differentiated tubular adenocarcinoma of ductal origin | Metastasis | |
Tissue Metastasized | Genetics | Mode of chromosome No.=142 at passage 20. CEA, CA, SLX were positive(passage27). | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | The tumor cell line is derived from pancreatic tissue originally. Adeno carcinoma cell line. The cells can be transplantable to nude mouse. |
Classify | tumor | Established by | Ikeda,Y. et.al. |
Registered by | Iguchi,H. | Regulation for Distribution | free |
Comment | Cells are observed to be unique from the STR-PCR analysis. | Year | 2001 |
Medium | RPMI1640 with 10% fetal calf serum. | Methods for Passages | 0.25% trypsin and 0.1 % EDTA in PBS. |
Cell Number on Passage | 3 x 10^4 cells/60 mm dish | Race | Japanese |
CO2 Conc. | Tissue Sampling | pancreas | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2172194 | Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice. Ikeda Y,Ezaki M,Hayashi I,Yasuda D,Nakayama K,Kono A Jpn J Cancer Res. 1990 Oct;81(10):987-93 |
Research results by users. Click! | |
---|---|
Pubmed id:none |
Cellular Membrane Localization of Innate Immune Checkpoint Molecule CD47 Is Regulated by Radixin in Human Pancreatic Ductal Adenocarcinoma Cells Takuro Kobori, Yui Ito, Yuka Sawada, Yoko Urashima, Takuya Ito and Tokio Obata Biomedicines.2023 Apr; 11(4): 1117 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB0181 | Cell Name | |
---|---|---|---|
LOT No. | 09262008 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum | Temperature | 37 C |
Cell Density at Seeding | 3 - 4 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA. Passage once a week. |
Doubling Time | approx. 2 days | Cell Number in Vial (cells/1ml) | 1.6 x 10^6 |
Viability at cell freezing (%) | 93.2 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0181 | Cell Name | |
---|---|---|---|
LOT No. | 04242003 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS lot; BioWhittaker 0S069F) | Temperature | 37 C |
Cell Density at Seeding | 5-8 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | D.T. =ca. 2.6 days | Cell Number in Vial (cells/1ml) | 1.0 x 10^6 |
Viability at cell freezing (%) | 91.1 | Antibiotics Used | free |
Passage Number | Unknown(6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD, AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS-RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0181 | Cell Name | KP-2 |
---|---|---|---|
LOT No. | 07282014 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | 0.25% trypsin and 0.1 % EDTA in PBS. | |
Doubling Time | approx 2 days | Cell Number in Vial (cells/1ml) | 7.4 x 10^5 |
Viability at cell freezing (%) | 99 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 99 | Additional information |
Cell No. | JCRB0181 | Cell Name | KP-2 |
---|---|---|---|
LOT No. | 05292018 | Lot Specification | distribution |
Medium | RPMI-1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 0.7 - 1.5 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 27 hrs. | Cell Number in Vial (cells/1ml) | 2.6 x 10^6 |
Viability at cell freezing (%) | 88.0 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI-1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 88.0 | Additional information |
Cell No. | JCRB0181 | Cell Name | KP-2 |
---|---|---|---|
LOT No. | 04122021 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO:catalog No.11875) with 10% heat inactivated fetal bovine serum(Biowest cat.No.S1820-500 LotNo.S09336S1820) | Temperature | 37 C |
Cell Density at Seeding | 1.22-1.25x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.1% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.33x10^6 |
Viability at cell freezing (%) | 100 | Antibiotics Used | free |
Passage Number | p8* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:9,13 D13S317:8,13 D7S820:10,12 D16S539:9,10 VWA:14 TH01:9 AM:X TPOX:8,11 CSF1PO:10,12 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 94 | Additional information |
Images |
---|
Cell No. | JCRB0181 | Cell Name | KP-2 |
---|---|---|---|
LOT No. | 11092021 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Biowest Cat. # S1820-500, Lot S09336S1820) | Temperature | 37 C |
Cell Density at Seeding | 0.3 - 1.1 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 34 hrs. | Cell Number in Vial (cells/1ml) | 1.6 x 10^6 |
Viability at cell freezing (%) | 100 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 98.8 | Additional information |